Plasma Adrenocorticotrophic Hormone in Congenital Adrenal Hyperplasia: Importance in Long-term Management

Stephen Lafranchi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In a prospective study, assays of plasma adrenocorticotrophic hormone (ACTH) were compared with established criteria to evaluate the determination's usefulness in monitoring the control of congenital adrenal hyperplasia (CAH). In 22 infants and children with 21-hydroxylase deficiency, the plasma ACTH value correctly identified the status of control in 51 of 73 (70%) patient visits. Plasma ACTH concentrations were significantly higher in patients whose conditions were out of control when compared with patients whose conditions were under control, although there was an overlap between the two groups. Plasma ACTH concentrations were significantly higher in patients with sodium-losing CAH than in patients with non-sodium-losing CAH. These findings support the concepts that patients with the sodium-losing condition have a more severe enzyme deficiency and that ACTH stimualtion may be affected by sodium balance. Although plasma ACTH determinations are a useful adjunct in the long-term management of CAH, they cannot be relied on as the sole criterion of control. (Am J Dis Child 134:1068-1072, 1980.

Original languageEnglish (US)
Pages (from-to)1068-1072
Number of pages5
JournalAmerican Journal of Diseases of Children
Volume134
Issue number11
DOIs
StatePublished - 1980

Fingerprint

Congenital Adrenal Hyperplasia
Adrenocorticotropic Hormone
Sodium
Prospective Studies
Enzymes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Plasma Adrenocorticotrophic Hormone in Congenital Adrenal Hyperplasia : Importance in Long-term Management. / Lafranchi, Stephen.

In: American Journal of Diseases of Children, Vol. 134, No. 11, 1980, p. 1068-1072.

Research output: Contribution to journalArticle

@article{9be866fb96f04b39a1d9c47f26d04c12,
title = "Plasma Adrenocorticotrophic Hormone in Congenital Adrenal Hyperplasia: Importance in Long-term Management",
abstract = "In a prospective study, assays of plasma adrenocorticotrophic hormone (ACTH) were compared with established criteria to evaluate the determination's usefulness in monitoring the control of congenital adrenal hyperplasia (CAH). In 22 infants and children with 21-hydroxylase deficiency, the plasma ACTH value correctly identified the status of control in 51 of 73 (70{\%}) patient visits. Plasma ACTH concentrations were significantly higher in patients whose conditions were out of control when compared with patients whose conditions were under control, although there was an overlap between the two groups. Plasma ACTH concentrations were significantly higher in patients with sodium-losing CAH than in patients with non-sodium-losing CAH. These findings support the concepts that patients with the sodium-losing condition have a more severe enzyme deficiency and that ACTH stimualtion may be affected by sodium balance. Although plasma ACTH determinations are a useful adjunct in the long-term management of CAH, they cannot be relied on as the sole criterion of control. (Am J Dis Child 134:1068-1072, 1980.",
author = "Stephen Lafranchi",
year = "1980",
doi = "10.1001/archpedi.1980.02130230048015",
language = "English (US)",
volume = "134",
pages = "1068--1072",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - Plasma Adrenocorticotrophic Hormone in Congenital Adrenal Hyperplasia

T2 - Importance in Long-term Management

AU - Lafranchi, Stephen

PY - 1980

Y1 - 1980

N2 - In a prospective study, assays of plasma adrenocorticotrophic hormone (ACTH) were compared with established criteria to evaluate the determination's usefulness in monitoring the control of congenital adrenal hyperplasia (CAH). In 22 infants and children with 21-hydroxylase deficiency, the plasma ACTH value correctly identified the status of control in 51 of 73 (70%) patient visits. Plasma ACTH concentrations were significantly higher in patients whose conditions were out of control when compared with patients whose conditions were under control, although there was an overlap between the two groups. Plasma ACTH concentrations were significantly higher in patients with sodium-losing CAH than in patients with non-sodium-losing CAH. These findings support the concepts that patients with the sodium-losing condition have a more severe enzyme deficiency and that ACTH stimualtion may be affected by sodium balance. Although plasma ACTH determinations are a useful adjunct in the long-term management of CAH, they cannot be relied on as the sole criterion of control. (Am J Dis Child 134:1068-1072, 1980.

AB - In a prospective study, assays of plasma adrenocorticotrophic hormone (ACTH) were compared with established criteria to evaluate the determination's usefulness in monitoring the control of congenital adrenal hyperplasia (CAH). In 22 infants and children with 21-hydroxylase deficiency, the plasma ACTH value correctly identified the status of control in 51 of 73 (70%) patient visits. Plasma ACTH concentrations were significantly higher in patients whose conditions were out of control when compared with patients whose conditions were under control, although there was an overlap between the two groups. Plasma ACTH concentrations were significantly higher in patients with sodium-losing CAH than in patients with non-sodium-losing CAH. These findings support the concepts that patients with the sodium-losing condition have a more severe enzyme deficiency and that ACTH stimualtion may be affected by sodium balance. Although plasma ACTH determinations are a useful adjunct in the long-term management of CAH, they cannot be relied on as the sole criterion of control. (Am J Dis Child 134:1068-1072, 1980.

UR - http://www.scopus.com/inward/record.url?scp=0019177324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019177324&partnerID=8YFLogxK

U2 - 10.1001/archpedi.1980.02130230048015

DO - 10.1001/archpedi.1980.02130230048015

M3 - Article

C2 - 6254355

AN - SCOPUS:0019177324

VL - 134

SP - 1068

EP - 1072

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 11

ER -